1 BTC
=
- USD
Cidara Therapeutics, Inc.
As of May 30, 2026 at 24:05 UTC
Chart
About Cidara Therapeutics, Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
Market Statistics
Trading Metrics
How to Buy CDTX
Create Your Account
Sign up, deposit BTC, and transfer it to your Unified Trading Account. It only takes a moment.
Start Your Trade
From Terminal, click Trade Now on the asset you want to buy. You'll be purchasing its tokenized asset.
Buy CDTX
Enter the amount and confirm your purchase. That's it! You'll see the impact of the trade in your Unified Trading Account.
New to Tokenized Assets? Learn more in our Help Center.
Latest News
5 articlesMerck's stock rose after positive clinical trial results for Winrevair, a pulmonary hypertension drug acquired through the Acceleron Pharmaceuticals acquisition. The company is strategically preparing for the Keytruda patent expiration in 2028 by developing new drugs and potential treatment expansions.
Merck's stock has experienced significant volatility, dropping from $130 to $76 and rebounding to around $100. Despite concerns about Keytruda's patent expiration in 2028, the company shows potential through new drug developments, acquisitions, and a promising pharmaceutical pipeline.
